B. Geeta et al. / Spectrochimica Acta Part A 77 (2010) 911–915
915
Acknowledgment
The authors thank the University Grant Commission (UGC, F. No.
34-363/2008(SR)), New Delhi, India for financially supporting this
research.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
References
Fig. 1. Comparison of MIC values (in g/mL) of complexes and standard drugs
against different bacteria.
[1] S. Akine, S. Sunaga, T. Taniguchi, H. Miyazaki, T. Nabeshima, Inorg. Chem. 46
(2007) 2959–2961.
[2] J.R. Anacona, E. Bastardo, J. Camus, Transit. Met. Chem. 24 (1999) 478–480.
[3] A. Trujillo, S. Sinbandhit, L. Toupet, D. Carrillo, C. Manzur, J.R. Hamon, J. Inorg.
Organomet. Polym. 18 (2008) 81–99.
[4] V. Lozan, C. Loose, J. Kortus, B. Kersting, Coord. Chem. Rev. 253 (2009)
2244–2260.
[5] S.A. Sallam, Transit. Met. Chem. 31 (2006) 46–55.
[6] J. Costamagna, J. Vargas, R. Latorre, A. Alvarado, G. Mena, Coord. Chem. Rev. 119
(1992) 67–88.
[7] J.M. Bindlish, S.C. Bhatia, P.C. Jain, Indian J. Chem. 13 (1975) 81–82.
[8] M.A. Ali, A.H. Mirza, M. Nazimuddin, F. Karim, P.V. Bernhardt, Inorg. Chim. Acta
358 (2005) 4548–4554.
[9] B.J.A. Jeragh, A. El-Dissouky, J. Coord. Chem. 58 (2005) 1029–1038.
[10] P.A. Vigato, S. Tamburini, Coord. Chem. Rev. 248 (2004) 1717–2128.
[11] S.M.E. Khalil, K.A. Bashir, J. Coord. Chem. 55 (2002) 681–696.
[12] M. Shakir, S.P. Varkey, Transit. Met. Chem. 19 (1994) 606–610.
[13] A.H. Al-Kubaisi, Bull. Korean Chem. Soc. 25 (2004) 37–41.
[14] P.M. Reddy, A.V.S.S. Prasad, K. Shanker, V. Ravinder, Spectrochim. Acta A 68
(2007) 1000–1006.
[15] P.M. Reddy, A.V.S.S. Prasad, V. Ravinder, Transit. Met. Chem. 32 (2007) 507–513.
[16] P.M. Reddy, K. Shanker, R. Rohini, M. Sarangapani, V. Ravinder, Spectrochim.
Acta A 70 (2008) 1231–1237.
[17] P.M. Reddy, A.V.S.S. Prasad, R. Rohini, V. Ravinder, Spectrochim. Acta A 70
(2008) 704–712.
[18] P.M. Reddy, A.V.S.S. Prasad, Ch.K. Reddy, V. Ravinder, Transit. Met. Chem. 33
(2008) 251–258.
[19] M. Ashok, A.V.S.S. Prasad, P.M. Reddy, V. Ravinder, Spectrochim. Acta A 72
(2009) 204–208.
[20] K. Shanker, R. Rohini, V. Ravinder, P.M. Reddy, Y.P. Ho, Spectrochim. Acta A 73
(2009) 205–211.
[21] P.M. Reddy, Y.P. Ho, K. Shanker, R. Rohini, V. Ravinder, Eur. J. Med. Chem. 44
(2009) 2621–2625.
[22] K. Shanker, P.M. Reddy, R. Rohini, Y.P. Ho, V. Ravinder, J. Coord. Chem. 62 (2009)
3040–3049.
[23] K. Shanker, R. Rohini, K. Shravankumar, P.M. Reddy, Y.P. Ho, V. Ravinder, J. Ind.
Chem. Soc. 86 (2009) 153–161.
[24] A. Prasad, P.M. Reddy, K. Shanker, R. Rohini, V. Ravinder, Color. Technol. 125
(2009) 284–287.
the compounds tested the four metal complexes showed good
inhibition towards all tested strains (Table 3). The activity of
dilution method in which the effectiveness was observed at lower
concentrations. The comparison of the MICs (in g/mL) of all
complexes and standard drugs against tested strains are presented
in Fig. 1 (Supplementary Table S1). It was found that Co(II), Ni(II),
Cu(II) complexes have good activity against all bacterial strains
with MIC value (15–35 g/mL). In particular, Pd(II) complex
showed excellent activity (MIC range 5–10 g/mL) against all
the bacterial strains even than standard drugs streptomycin
and ampicillin. The results from these studies have also shown
that complexation of metals to CMAIPA serves to improve the
antimicrobial of the ligand. This higher antibacterial activity of the
metal complexes compared to ligand is may be due to the change
in structure due to coordination and chelating tends to make
metal complexes act as more powerful and potent bactereostatic
agents, thus inhibiting the growth of the bacteria. Furthermore,
partial sharing of its positive charge with the donor groups within
the chelate ring system. Such chelation increases the lipophilic
nature of the central metal atom, which favors its permeation
more efficiently through the lipid layer of the microorganism, thus
destroying them more forcefully [20,40–42]. Thus all complexes
showed more increased activity than the corresponding ligand
and the two antibacterial drugs. The activity of ligand, complexes
and standard drugs against different bacteria were found to be
CMAIPA(L) < streptomycin < [Ni2L(H2O)4]·3H2O = ampicillin < [Co2
L(H2O)4]·3H2O < [Cu2L]·3H2O < [Pd2L] < rifampicin for S. aureus,
CMAIPA(L) = streptomycin < ampicillin<[Ni2L(H2O)4]·3H2O<[Cu2L]·
3H2O < [Co2L(H2O)4]·3H2O < [Pd2L] < rifampicin for B. subtilis,
streptomycin<CMAIPA(L) =ampicillin<[Co2L(H2O)4]·3H2O < [Cu2L]·
3H2O [Ni2L(H2O)4]·3H2O<[Pd2L]<rifampicin for E. coli and strepto-
mycin < ampicillin<CMAIPA(L) < [Co2L(H2O)4]·3H2O<[Ni2L(H2O)4]·
3H2O < [Cu2L]·3H2O < [Pd2L] < rifampicin for K. pneumonia.
[25] R. Rohini, K. Shanker, P.M. Reddy, Y.-P. Ho, V. Ravinder, Eur. J. Med. Chem. 44
(2009) 3330–3339.
[26] R. Rohini, K. Shanker, P.M. Reddy, V.C. Sekhar, V. Ravinder, Arch. Pharm. 342
(2009) 533–540.
[27] R. Rohini, P.M. Reddy, K. Shanker, V. Ravinder, Acta Chim. Slov. 56 (2009)
900–907.
[28] R. Rohini, K. Shanker, P.M. Reddy, V. Ravinder, J. Braz. Chem. Soc. 21 (2010)
49–57.
[29] W.J. Geary, Coord. Chem. Rev. 7 (1971) 81–122.
[30] W.R. Marson, H.B. Gray, J. Am. Chem. Soc. 90 (1968) 5721–5729.
[31] E. Keskioglu, A.B. Gunduzalp, S. C¸ ete, F. Hamurcu, B. Erk, Spectrochim. Acta A
70 (2008) 634–640.
[32] S. Chandra, R. Kumara, R. Singh, Spectrochim. Acta A 65 (2006) 215–220.
[33] J. Bjerrum, C.J. Ballhausen, C.K. Jorgensen, Acta Chem. Scand.
1275–1289.
8 (1954)
[34] R.L. Carlin, A.J. Vandryneveledt, Magnetic Properties of Transition Metal Com-
pounds, Springer-Verlag, New York, 1997.
5. Conclusions
[35] S.S. Tandon, L.C. Laurence, K. Thompson, S.P. Connors, J.N. Bridson, Inorg. Chem.
Acta 213 (1993) 289–300.
In this report the non-template synthesis of new binuclear
cobalt(II), nickel(II), copper(II), and palladium(II) complexes having
N4O4 Schiff-base ligand obtained by condensation of glycyl–glycine
with o-phthalaldehyde have been presented and all the synthesized
compounds were screened for their antibacterial activity against
two Gram-positive and two Gram-negative bacterial strains. In this
study the most potent activity was observed in Pd(II) complex
against all tested strains when compared to respective standard
drugs streptomycin and ampicillin.
[36] Z. Wang, Z. Wu, Z. Yen, Transit. Met. Chem. 19 (1994) 235–236.
[37] A.S. El Tabl, Polish J. Chem. 71 (1997) 1213–1222.
[38] B.A. Goodman, J.B. Raynor, Adv. Inorg. Chem. Radiochem. 13 (1970) 136–362.
[39] R. Rohini, P.M. Reddy, K. Shanker, A. Hu, V. Ravinder, Eur. J. Med. Chem. 45
(2010) 1200–1205.
[40] B.G. Tweedy, Phytopathology 55 (1964) 910–914.
[41] N.M.A. Atabay, B. Dulger, F. Gucin, Eur. J. Med. Chem. 40 (2005) 1096–1102.
[42] S.A. Patil, V.H. Naik, A.D. Kulkarni, P.S. Badami, Spectrochim. Acta A 75 (2010)
347–354.